We employed ELISA to analyze the levels of injury markers in cardiomyocytes under different experimental conditions, following the guidelines provided by the manufacturer (Beyotime, China).
Copyright and License information: ©2024 The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
Post a Question 0 Q&A